PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution
Contribuinte(s) |
Universidade Estadual Paulista (UNESP) |
---|---|
Data(s) |
20/05/2014
20/05/2014
16/02/2005
|
Resumo |
Praziquantel has been shown to be highly effective against all known species of Schistosoma infecting humans. Spherical nanoparticulate drug carriers made of poly(D,L-lactide-co-glycolide) acid with controlled size were designed. Praziquantel, a hydrophobic molecule, was entrapped into the nanoparticles with theoretical loading varying from 10 to 30% (w/w). This investigates the effects of some process variables on the size distribution of nanoparticles prepared by emulsion-solvent evaporation method. The results show that sonication time, PLGA and drug amounts, PVA concentration, ratio between aqueous and organic phases, and the method of solvent evaporation have a significant influence on size distribution of the nanoparticles. (C) 2004 Elsevier B.V. All rights reserved. |
Formato |
137-144 |
Identificador |
http://dx.doi.org/10.1016/j.ijpharm.2004.11.027 International Journal of Pharmaceutics. Amsterdam: Elsevier B.V., v. 290, n. 1-2, p. 137-144, 2005. 0378-5173 http://hdl.handle.net/11449/7591 10.1016/j.ijpharm.2004.11.027 WOS:000226985500015 |
Idioma(s) |
eng |
Publicador |
Elsevier B.V. |
Relação |
International Journal of Pharmaceutics |
Direitos |
closedAccess |
Palavras-Chave | #nanoparticles #controlled release #PLGA #praziquantel #emulsification evaporation method |
Tipo |
info:eu-repo/semantics/article |